BRENTWOOD, Tennessee (WKRN) – Another headquarters calls Tennessee home.
Pharmaceutical Currax, a specialty biopharmaceutical company dedicated to expanding access to clinically differentiated and underrated medicines, both branded and generic, last week hosted a groundbreaking celebration for its new headquarters in Brentwood, near Franklin Road.
“It’s a pretty exciting time in Nashville. The healthcare system is already accelerating so well, ”said George Hampton, President and CEO of Currax Pharmaceuticals.
According to a study by the Nashville Health Care Council and the Business and Economic Research Center at Middle Tennessee State University, by 2022 in Tennessee, health care will represent one in 11 new jobs. By 2028, this number is expected to reach one in eight jobs.
“We are focused on diseases with very high unmet need where we believe we can have an impact,” said Hampton.
“We needed a talent pool to draw from, and over the past 5-7 years, I’m not sure if a metro area has benefited more than Nashville from the influx of new talent. “
The company was born in New Jersey and now has nearly 30 drugs, investing heavily in obesity.
“We see ourselves as a patient-focused pharmaceutical company, and what that means to us is that profit is a side effect of doing what’s right for the patient,” said Hampton. “It’s sort of a lost art in the pharmaceutical industry and sometimes in all healthcare. The patient is not the first, he is the last. We try to keep them first.
Hampton also hopes to bring density, jobs, prosperity and interest to area schools.
The latest news reaches you: Subscribe to News 2 email alerts →
Currax’s new head office will have around 35 employees and will serve as a central office for the management and head office teams. The company plans to add 20 more positions to the Brentwood office in the near future, while one of its main goals is to recruit locally.